Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production (scientific article published on 7 March 2006)

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

Q33629928

Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

Q34386649

Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity

Q34505678

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Q34515741

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

Q34516841

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

Q34527240

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

Q34561791

CD4+ CD25+ suppressor T cells: more questions than answers

Q34716304

Shifting foci of hematopoiesis during reconstitution from single stem cells

Q35122188

In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets

Q35847952

Tolerance, not immunity, crucially depends on IL-2.

Q35877199

Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells.

Q36369780

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

Q36402763

Identification of the Immunophilins Capable of Mediating Inhibition of Signal Transduction by Cyclosporin A and FK506: Roles of Calcineurin Binding and Cellular Location

Q36694583

Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells

Q38323893

Early IL-2 Production by Mouse Dendritic Cells Is the Result of Microbial-Induced Priming

Q40649514

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response

Q40651436

Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells

Q41743877

Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma.

Q43829312

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

Q43873032

Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells

Q44072016

Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

Q44189640

New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.

Q44200460

The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade

Q44217780

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

Q44408941

Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery

Q44741787

Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model

Q45251857

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

Q45299244

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

Q46739924

Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function

Q47579310

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

Q54073234

Activation requirements for the induction of CD4+CD25+ T cell suppressor function

Q56903555

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

Q56904280

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

Q57202280

Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors

Q70055061

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

Q71029782

Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome

Q72574737

Combination therapy with a CD4-CDR3 peptide analog and cyclosporin A to prevent graft-vs-host disease in a MHC-haploidentical bone marrow transplantation model

Q74063423

Mycophenolate mofetil impairs the maturation and function of murine dendritic cells

Q74183071

Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction

Q74191513

CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2

Q74660381

Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes

Q77758613

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

Q78033315

P433

issue

P407

language of work or name

English